Latest Articles

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

What do us physicians and patients think about LLTs and goals of treatment?

Physician and patient perceptions of benefits, risks, and treatment goals of lipid-lowering therapy: Results from GOULD registry.

APSC Consensus Recommendations on Dyslipidemia

VTE incidence after cesarean delivery

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Use of Lipid-Lowering Therapies Over 2 Years

Prescription patterns of lipidlowering therapies over time in patients with atherosclerotic cardiovascular disease: Findings from Gould study

Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Single injectable treatment may not be enough to get T2DM patient to Glycemic goal

Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia